Matches in SemOpenAlex for { <https://semopenalex.org/work/W4382893429> ?p ?o ?g. }
Showing items 1 to 55 of
55
with 100 items per page.
- W4382893429 endingPage "101897" @default.
- W4382893429 startingPage "101897" @default.
- W4382893429 abstract "Heart failure is a complex condition which is prevalent worldwide. Heart failure is also the leading cause of hospitalizations among individuals aged 65 and above. On May 26, Sotagliflozin, a dual SGLT-1 and SGLT-2 inhibitor, has recently been approved for the treatment of heart failure. Heart failure is the leading cause of hospitalizations for individuals aged 65 and above. The approval comes after clinical trials where a significant decrease in hospital visits, urgency and heart failure hospitalisation was seen. Therefore, it could be a potential breakthrough in the field of cardiology, as reduced hospitalizations will in turn reduce the burden on health care facilities. However, further research is required to see the long term effects of the drug." @default.
- W4382893429 created "2023-07-03" @default.
- W4382893429 creator A5039070711 @default.
- W4382893429 creator A5063263678 @default.
- W4382893429 date "2023-11-01" @default.
- W4382893429 modified "2023-09-24" @default.
- W4382893429 title "Letter to the Editor: Latest FDA Approved drug Sotagliflozin (Inpefa): a glance at its prospectives for heart failure" @default.
- W4382893429 cites W2995319359 @default.
- W4382893429 cites W3100542962 @default.
- W4382893429 cites W3120249811 @default.
- W4382893429 doi "https://doi.org/10.1016/j.cpcardiol.2023.101897" @default.
- W4382893429 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37402421" @default.
- W4382893429 hasPublicationYear "2023" @default.
- W4382893429 type Work @default.
- W4382893429 citedByCount "0" @default.
- W4382893429 crossrefType "journal-article" @default.
- W4382893429 hasAuthorship W4382893429A5039070711 @default.
- W4382893429 hasAuthorship W4382893429A5063263678 @default.
- W4382893429 hasConcept C126322002 @default.
- W4382893429 hasConcept C164705383 @default.
- W4382893429 hasConcept C177713679 @default.
- W4382893429 hasConcept C2778198053 @default.
- W4382893429 hasConcept C2780035454 @default.
- W4382893429 hasConcept C535046627 @default.
- W4382893429 hasConcept C71924100 @default.
- W4382893429 hasConcept C98274493 @default.
- W4382893429 hasConceptScore W4382893429C126322002 @default.
- W4382893429 hasConceptScore W4382893429C164705383 @default.
- W4382893429 hasConceptScore W4382893429C177713679 @default.
- W4382893429 hasConceptScore W4382893429C2778198053 @default.
- W4382893429 hasConceptScore W4382893429C2780035454 @default.
- W4382893429 hasConceptScore W4382893429C535046627 @default.
- W4382893429 hasConceptScore W4382893429C71924100 @default.
- W4382893429 hasConceptScore W4382893429C98274493 @default.
- W4382893429 hasIssue "11" @default.
- W4382893429 hasLocation W43828934291 @default.
- W4382893429 hasLocation W43828934292 @default.
- W4382893429 hasOpenAccess W4382893429 @default.
- W4382893429 hasPrimaryLocation W43828934291 @default.
- W4382893429 hasRelatedWork W1998556240 @default.
- W4382893429 hasRelatedWork W2012241433 @default.
- W4382893429 hasRelatedWork W2039995053 @default.
- W4382893429 hasRelatedWork W2076843464 @default.
- W4382893429 hasRelatedWork W2125804349 @default.
- W4382893429 hasRelatedWork W2304633692 @default.
- W4382893429 hasRelatedWork W2399063111 @default.
- W4382893429 hasRelatedWork W4237806278 @default.
- W4382893429 hasRelatedWork W4247718175 @default.
- W4382893429 hasRelatedWork W4313444034 @default.
- W4382893429 hasVolume "48" @default.
- W4382893429 isParatext "false" @default.
- W4382893429 isRetracted "false" @default.
- W4382893429 workType "letter" @default.